Literature DB >> 13362281

Penicillamine, a new oral therapy for Wilson's disease.

J M WALSHE.   

Abstract

Entities:  

Keywords:  CYSTEINE/related compounds; DIMERCAPROL/therapeutic use; HEPATOLENTICULAR DEGENERATION/therapy

Mesh:

Substances:

Year:  1956        PMID: 13362281     DOI: 10.1016/0002-9343(56)90066-3

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  104 in total

Review 1.  A comparative study of in vitro and in vivo interaction of D-penicillamine and triethylenetetramine with copper.

Authors:  B Sarkar; A Sass-Kortsak; R Clarke; S H Laurie; P Wei
Journal:  Proc R Soc Med       Date:  1977

2.  Wilson's Disease.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  2000-05       Impact factor: 3.598

3.  Isolation of the first crystalline D-penicillamine complex of iron and some remarks on relevant aspects of metal-chelating drugs as well as metabolism disorders.

Authors:  A Müller; M Straube; E Krickemeyer; H Bögge
Journal:  Naturwissenschaften       Date:  1992-07

4.  LEAD POISONING IN CHILDREN.

Authors:  A A MONCRIEFF; O P KOUMIDES; B E CLAYTON; A D PATRICK; A G RENWICK; G E ROBERTS
Journal:  Arch Dis Child       Date:  1964-02       Impact factor: 3.791

5.  DISORDERS OF AMINO-ACID TRANSPORT.

Authors:  M D MILNE
Journal:  Br Med J       Date:  1964-02-08

6.  Treatment of lead-poisoning with oral penicillamine.

Authors:  A GOLDBERG; J A SMITH; A C LOCHHEAD
Journal:  Br Med J       Date:  1963-05-11

7.  Discussion on some clinical, genetic and biochemical aspects of metabolic disorders of the nervous system: metabolic disease of the nervous system: clinical aspects.

Authors:  W B MATTHEWS
Journal:  Proc R Soc Med       Date:  1958-10

Review 8.  Neurologically presenting Wilson's disease: epidemiology, pathophysiology and treatment.

Authors:  George J Brewer
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

9.  Wilson's disease-cause of mortality in 164 patients during 1992-2003 observation period.

Authors:  A Członkowska; B Tarnacka; T Litwin; J Gajda; M Rodo
Journal:  J Neurol       Date:  2005-03-02       Impact factor: 4.849

10.  Effective treatment of Wilson's disease with oral zinc sulphate: two case reports.

Authors:  T U Hoogenraad; C J Van den Hamer; J Van Hattum
Journal:  Br Med J (Clin Res Ed)       Date:  1984-08-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.